A
43
2
MU
42
14
SNA
56
3
PX
56
3
IPG
43
3
ILMN
31
4
NRG
32
5
BEN
36
4
UA
48
6
HBI
53
4
BXP
39
5
AKAM
50
2
AMGN
42
14
HSY
32
3
HES
49
2
CPB
24
2
TGNA
48
5
CHRW
53
2
AEP
45
5
NSC
33
6
A
43
2
MU
42
14
SNA
56
3
PX
56
3
IPG
43
3
ILMN
31
4
NRG
32
5
BEN
36
4
UA
48
6
HBI
53
4
BXP
39
5
AKAM
50
2
AMGN
42
14
HSY
32
3
HES
49
2
CPB
24
2
TGNA
48
5
CHRW
53
2
AEP
45
5
NSC
33
6
Financhill
Back

Janux Therapeutics Stock Predictions

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here
Sell
28

JANX
Janux Therapeutics

Last Price:
$56.16
Seasonality Move:
84.76%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.

Janux Therapeutics Stock Forecast

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 146.4% based on the past 3 years of stock performance.
  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Janux Therapeutics Stock Undervalued?
    The current Janux Therapeutics [JANX] share price is $56.71. The Score for JANX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Janux Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 146.4% based on the past 3 years of stock performance.

Janux Therapeutics Stock Rating

Sell
28
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics overpriced?

  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Janux Therapeutics Stock Price History

Is JANX stock going to rise?

  • The current trend is moderately bearish and JANX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com

52-Week Data

52-Week High:
71.71
52-Week Low:
7.79

Prediction Charts

Market Cap:
3B
Price in USD:
56.71
Volume:
1.3M
Beta:
3.37

Technical Analysis

SMA50:
53.90
SMA100:
48.93
SMA200:
46.87
52-Wk Change:
495.07%

Stock Predictions

  • Is Janux Therapeutics stock public?
    Yes, Janux Therapeutics is a publicly traded company.
  • What is the Janux Therapeutics stock quote today?
    The Janux Therapeutics stock price is 56.71 USD today.
  • How to buy Janux Therapeutics stock online?
    You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 67.17 59.86 71.25 59.30
Dec-4 60.00 66.84 70.03 56.71
Dec-5 67.40 66.30 71.71 64.87
Dec-6 66.33 64.99 68.99 64.32
Dec-9 63.79 61.65 65.29 61.16
Dec-10 61.45 62.36 66.34 61.02
Dec-11 62.44 63.45 65.29 61.29
Dec-12 64.00 61.50 64.90 61.27
Dec-13 61.24 61.11 63.86 60.26
Dec-16 60.66 61.56 63.00 60.50
Dec-17 61.10 59.61 62.30 58.96
Dec-18 59.37 55.13 60.00 54.56
Dec-19 54.55 56.75 57.98 54.20
Dec-20 56.37 56.71 59.72 55.63

Janux Therapeutics Earnings

Janux Therapeutics Earnings Report: Per Share Janux Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Janux Therapeutics Forecast Revenue Growth

Janux Therapeutics Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.97 per share.

* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.